Briefs: Panacea Biotec and Shukra Pharmaceuticals
News

Briefs: Panacea Biotec and Shukra Pharmaceuticals

Panacea Biotec receives acceptance from CMSS for supply of bOPV

  • By IPP Bureau | October 09, 2025

Panacea Biotec receives acceptance from CMSS for supply of bOPV

The Central Medical Services Society (CMSS), Ministry of Health and Family Welfare, Government of India has accepted the Panacea Biotec’s offer for supply of bivalent oral polio vaccine (bOPV) against the tender issued by it in this regard. Panacea will supply the vaccine worth Rs.127.20 crore in several tranches over a period of 90 - 480 days from the date of issuance of LOA.

Shukra Pharmaceuticals receives order from Meril Healthcare

Meril Healthcare Private Limited, an Original Equipment Manufacturer (OEM) of advanced orthopaedic and robotic systems, has authorized Shukra Pharmaceuticals for the "Robotic Assisted Surgery System for Orthopedics" projects at Directorate General Armed Forces Medical Services (DGAFMS), Ministry of Defence and INHS Asvini, Colaba, Mumbai (Maharashtra). This strategic collaboration marks Shukra Pharmaceuticals' entry into the high-growth medical robotics and advanced orthopaedic healthcare technology segment.

Upcoming E-conference

Other Related stories

Startup

Digitization